| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Moxonidine | Moxonidine Dihydroxy Impurity | VL1440005 | View CAS 352457-32-0 |
| Moxonidine | Moxonidine EP Impurity A | VL1440003 | View CAS 352457-35-3 |
| Moxonidine | Moxonidine EP Impurity B | VL1440004 | View CAS 75439-01-9 |
| Moxonidine | Moxonidine EP Impurity C | VL1440001 | View CAS 352457-34-2 |
| Moxonidine | Moxonidine Impurity D Chloro-Hydroxy | VL1440002 | View CAS 352457-33-1 |
| Moxonidine | Nitroso | N-Nitroso-Moxonidine (mononitroso) | VE007642 | View |
| Catalogue No. | VL1440005 |
| CAS No. | 352457-32-0 |
| Molecular Formula | C8H11N5O2 |
| Molecular Weight | 209.21 |
| Parent drug | Moxonidine |
| IUPAC Name | 5-(imidazolidin-2-ylideneamino)-2-methylpyrimidine-4, 6-diol |
| Synonyms | N/A |
| References | Sci-Hub, Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans, 10.1124/dmd.31.3.334. (2021). Retrieved December 1, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.1124/dmd.31.3.334 ? |
| Status | In-stock |
| ListName | Moxonidine Dihydroxy Impurity |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
